Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
54,405,738
-
Total 13F shares
-
24,696,152
-
Share change
-
+24,693,134
-
Total reported value
-
$417,257,187
-
Price per share
-
$16.92
-
Number of holders
-
43
-
Value change
-
+$417,206,204
-
Number of buys
-
42
Institutional Holders of Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (ZBIO) as of Q3 2024
As of 30 Sep 2024,
Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (ZBIO) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,696,152 shares.
The largest 10 holders included
SR One Capital Management, LP, NEA Management Company, LLC, FMR LLC, Fairmount Funds Management LLC, NVP Associates, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, FEDERATED HERMES, INC., and Novo Holdings A/S.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.